Industry · Pharmaceuticals & BioTech
Pharmaceuticals & BioTech
Support Medical Affairs, HEOR, and development teams moving from protocol to screened literature to a finding that stands up in review—without a black box.
The challenge
Pharma and biotech evidence work spans indications, competitors, safety language, and value stories. Manual reviews are slow; opaque AI tools fail internal and medical review. Teams need speed and a trail that MSLs, reviewers, and leadership can follow.
How LRN works here
A workflow your team can defend
-
01
Frame the question
Lock population, intervention, comparator, and outcomes the way your reviewers already think—then bind them to searchable literature.
-
02
Screen with Explainable AI
Include/exclude decisions leave linked terms and confidence signals; humans re-include with a logged trail.
-
03
Synthesize and brief
Themes, findings, and citations stay attached so Medical Affairs can brief without losing the source path.
-
04
Package for scrutiny
AI Package Insert-style lineage—data, model rationale, human gates, and outputs—ready for QA.
What you leave with
Defensible findings
Claims tied to included studies, not free-floating summaries.
Inspectable process
Screening and overrides available for medical and compliance review.
Faster cycles
Compress long manual timelines while keeping methods integrity.
Next step
Talk with us about LRN for pharmaceuticals and biotech.